Literature DB >> 15026257

Electrophysiological and behavioral effects of zolpidem in rat globus pallidus.

Lei Chen1, C Savio Chan, Wing-Ho Yung.   

Abstract

The globus pallidus is believed to play a critical role in the normal function of the basal ganglia, and abnormal activity of its neurons may underlie some basal ganglia motor symptoms. A high density of benzodiazepine binding sites on GABAA receptors has been reported in the rat globus pallidus. The present study investigates the effect of activating the benzodiazepine site by the agonist zolpidem. In in vitro slices, 100 nM of zolpidem significantly prolonged the half decay time of both miniature and spontaneous inhibitory postsynaptic currents by 30.1 +/- 3.0% (n=12) and 17.8 +/- 2.4% (n=16), respectively, with no effect on their amplitudes and frequencies. In the behaving animal, when zolpidem was microinjected into the globus pallidus unilaterally, it caused a robust ipsilateral rotation (26.4 +/- 2.4 turns/30 min, n=8), significantly higher than that of control animals receiving vehicle injection (1.3 +/- 1.6 turns/30 min, n=6). This effect was in agreement with the in vitro effect of zolpidem in enhancing the action of GABA on postsynaptic GABAA receptors. All the effects of zolpidem, in vitro or in vivo, were sensitive to the benzodiazepine antagonist flumazenil, confirming the specificity on the benzodiazepine site. This finding on the effect of zolpidem on motor behavior provides a rationale for further investigations into its potential in the treatment of motor disorders originating from the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026257     DOI: 10.1016/j.expneurol.2003.11.003

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  13 in total

Review 1.  The external globus pallidus: progress and perspectives.

Authors:  Daniel J Hegeman; Ellie S Hong; Vivian M Hernández; C Savio Chan
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

2.  Effects of Pharmacological Block of GABA(A) Receptors on Pallidal Neurons in Normal and Parkinsonian State.

Authors:  Yan Xue; Xiao-Hua Han; Lei Chen
Journal:  Front Cell Neurosci       Date:  2010-02-22       Impact factor: 5.505

Review 3.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

Review 4.  General anesthesia, sleep, and coma.

Authors:  Emery N Brown; Ralph Lydic; Nicholas D Schiff
Journal:  N Engl J Med       Date:  2010-12-30       Impact factor: 91.245

5.  Longitudinal alterations in gamma-aminobutyric acid (GABAA) receptor availability over ∼ 1 year following traumatic brain injury.

Authors:  Y Kang; K Jamison; A Jaywant; K Dams-O'Connor; N Kim; N A Karakatsanis; T Butler; N D Schiff; A Kuceyeski; S A Shah
Journal:  Brain Commun       Date:  2022-06-15

Review 6.  Recovery of consciousness after brain injury: a mesocircuit hypothesis.

Authors:  Nicholas D Schiff
Journal:  Trends Neurosci       Date:  2009-12-01       Impact factor: 13.837

7.  Efficacy of zolpidem for dystonia: a study among different subtypes.

Authors:  Yoshimichi Miyazaki; Wataru Sako; Kotaro Asanuma; Yuishin Izumi; Tetsuro Miki; Ryuji Kaji
Journal:  Front Neurol       Date:  2012-04-17       Impact factor: 4.003

Review 8.  Turning a Negative into a Positive: Ascending GABAergic Control of Cortical Activation and Arousal.

Authors:  Ritchie E Brown; James T McKenna
Journal:  Front Neurol       Date:  2015-06-11       Impact factor: 4.003

Review 9.  GABA(A) receptors: structure and function in the basal ganglia.

Authors:  T Goetz; A Arslan; W Wisden; P Wulff
Journal:  Prog Brain Res       Date:  2007       Impact factor: 2.453

10.  Flavonoid Myricetin Modulates GABA(A) Receptor Activity through Activation of Ca(2+) Channels and CaMK-II Pathway.

Authors:  Xiao Hu Zhang; Ze Gang Ma; Dewi Kenneth Rowlands; Yu Lin Gou; Kin Lam Fok; Hau Yan Wong; Mei Kuen Yu; Lai Ling Tsang; Li Mu; Lei Chen; Wing Ho Yung; Yiu Wa Chung; Bei Lin Zhang; Hua Zhao; Hsiao Chang Chan
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-11       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.